ILevetiracetam LEV CAS 102767-28-2 API Factory USP EP Standard High Purity
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leKhemikhali: Levetiracetam
CAS: 102767-28-2
I-API USP / EP Standard, iMveliso yoRhwebo
Isizukulwana sesithathu se-Antiepileptic Drug
Igama leMchiza | Levetiracetam |
Izithethantonye | LEV;(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide;UCB-L059 |
Inombolo yeCAS | 102767-28-2 |
Inombolo yeCAT | RF-API61 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C8H14N2O2 |
Ubunzima beMolekyuli | 170.21 |
Indawo yokunyibilika | 116.0-119.0℃ |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe okanye ophantse wamhlophe |
Ukuchongwa kwe-IR | ISpectrum efunyenwe kwisampulu iqulathe leyo ifunyenwe kwireferensi |
Imbonakalo yesisombululo | Icacile kwaye ingabi mbala kakhulu kune-BY6 |
Ukungcola kwe-Enantiomeric D | ≤0.80% |
Amanzi | ≤0.50% |
Uthuthu lweSulfated | ≤0.10% |
Iintsimbi ezinzima | ≤0.001% |
Izinto ezinxulumeneyo | |
Ukungcola A | ≤0.30% |
Nakuphi na Ukungcola Okungachazwanga | ≤0.05% |
Ukungcola okungachazwanga ngokupheleleyo | ≤0.10% |
Ukungcola ngokupheleleyo | ≤0.40% |
Ukungcola F | ≤0.10% |
Izinyibilikisi ezishiyekileyo | |
Benzeni | ≤2ppm |
Dichloromethane | ≤600ppm |
I-Ethyl Acetate | ≤5000ppm |
I-acetone | ≤5000ppm |
Isivavanyi | 98.0%~102.0% |
Umgangatho woVavanyo | Umgangatho we-USP;EP Umgangatho |
Ukusetyenziswa | API Isizukulwana Sesithathu Antiepileptic Drug |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
I-Levetiracetam (i-CAS: i-102767-28-2), i-derivative ye-pilacetam, iyinoveli ye-antiepileptic yesizukulwana sesithathu esivunywe yi-US FDA kwi-1999. Ekuqaleni yayisetyenziselwa unyango oluncedisayo lokubanjwa okuyingxenye kubantu abadala.Kwi-2005, i-Levetiracetam yavunywa kwiipilisi zomlomo kunye nezisombululo zonyango oluncedisayo lokubanjwa okuyingxenye kubantwana abaneminyaka eyi-4 nangaphezulu.Isetyenziswa ikakhulu kunyango olongezelelweyo lokuxhuzula inxalenye yabantu abadala kunye nabantwana abangaphezu kweminyaka emi-4 ubudala, kwaye ingasetyenziselwa kuphela ukuxhuzula okuyingxenye kunye nokuxhuzula kwenkqubo kubantu abadala.Ikwanazo nefuthe elithile lokunyanga kwi-myoclonic epilepsy kulutsha, ukuxhuzula okunqandayo, ukuxhuzula okungabikho ebantwaneni kunye nokuxhuzula okuzingisileyo.
-
Levetiracetam LEV CAS 102767-28-2 API Factory U...
-
(S)-2-Aminobutyramide Hydrochloride CAS 7682-20...
-
(R) -2-Aminobutanamide Hydrochloride CAS 103765-...
-
Pregabalin CAS 148553-50-8 Ubunyulu > 99.0% (HPLC)...
-
Perindopril Erbumine CAS 107133-36-8 Ubunyulu >99...
-
Olaparib AZD-2281 CAS 763113-22-0 Ubunyulu ≥99.0%.
-
Isiseko seLapatinib CAS 231277-92-2 Ubunyulu ≥99.0% (H...
-
Irinotecan Hydrochloride Trihydrate CAS 136572-...
-
Isiseko sasimahla se-Irinotecan CAS 97682-44-5 Assay ≥99.0...
-
Ibrutinib CAS 936563-96-1 Ubunyulu > 99.5% (HPLC) API
-
I-Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~1...
-
Fingolimod Hydrochloride CAS 162359-56-0 Ubunyulu...
-
Gabapentin CAS 60142-96-3 Ubunyulu > 99.5% (HPLC) ...
-
Gemcitabine Hydrochloride CAS 122111-03-9 API U...
-
Gliepiride CAS 93479-97-1 Assay 98.0%~102.0% A...
-
Enalapril Maleate CAS 76095-16-4 Assay 98.0~102...